5 provincial procurement alliance will come, a large number of injections to reduce prices!

Recently, Yunnan Province, Hunan Province, Chongqing City, Guizhou Province, Guangxi Zhuang Autonomous Region, the first batch of commonly used drugs combined with the volume of procurement documents for comments on the draft was officially released.
documents show that 18 varieties, such as phenyl sulfonate lamine chlorpyridine, pyridoxine, cephalosporine, sodium pentolatin, zucarnitine, hydrochloric acid, growth inhibitor, sodium chloride, etc., will be collected jointly.
In addition, the document also shows that the five provinces and cities joint procurement area agreed procurement volume calculation base, from January 1, 2019 to December 31, 2019 Chongqing, Guizhou, Yunnan, Hunan, Guangxi medical institutions reported 70% of the procurement demand is determined.
, it is worth noting that most of the drugs purchased in the five provinces are injection forms.
, just a few days ago, Sichuan and other eight provinces and regions of the health insurance bureau also issued on the inter-provincial alliance drug centralized belt procurement work announcement.
17 varieties, such as curtin injections, cytophosphocholine injections, lansolazole injections, renitin injections, medazole injections, and methazole injections, were included, 15 of which were also injection forms.
this, the industry generally believes that since the previous Shanxi Province with the volume of the purchase of varieties are all injections, all over the collection of more injection varieties has become a trend.
data show that injections account for more than 60% of China's public hospital drug market, including chemical injections even reached 70%, injections have more than 33,000 approvals.
2018, the market size of injections has exceeded trillion yuan, including billions of varieties sold annually.
to some extent, the injection belt procurement amount is high, the dosage is large, in line with the provinces with volume procurement of varieties selection objectives, so it is very easy to become a band procurement varieties.
But as more and more injectable varieties are included in joint procurement, the industry expects that once inter-provincial alliances form a climate and face such a large market, the vast majority of pharmaceutical companies will choose to "price-for-volume" to gain more market share and profit margins.
, the provincial drug pattern may be remodeled, prices are expected to be deep game, or set off a wave of injection collection and price reduction.
In addition, it is worth noting that from the above-mentioned joint mining model, inter-provincial alliance mining because of the large size of the market, more attractive to enterprises, easier to form a model to promote, has also become the trend of the collection.
the future, with the emergence of "procurement alliances", prices such as drugs may be more reasonable and benefit more patients.
, as more and more provinces and cities have seen the results of injection belt procurement, special procurement of the vast majority of injectable varieties that have not yet been evaluated may inspire other provinces.
time, this may speed up the process of volume procurement around injections at the national level and throughout the country.
industry forecast that the future of injections will become a large probability of local volume procurement targets, trillion market reshuffle is coming.